Introduction to FBDD Technology

Novorex's drug development platform uses Fragment-based Drug Discovery (FBDD), which is a powerful approach that involves screening and optimizing small, low molecular weight compounds known as fragments. With FBDD, Novorex can efficiently screen large chemical libraries and identify novel drug candidates with high potency, selectivity, and other drug-like properties.

This approach allows Novorex to explore a wide chemical space and discover new chemical scaffolds for optimizing therapeutic efficacy. Overall, FBDD is a critical technology for Novorex's drug development efforts, enabling the company to advance novel and effective therapies for a wide range of diseases.